Cetera Advisor Networks LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cetera Advisor Networks LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$483,000
+68.3%
13,500
+23.0%
0.03%
+70.0%
Q3 2014$287,000
+7.9%
10,975
+36.8%
0.02%
+17.6%
Q2 2014$266,000
+26.1%
8,025
+12.6%
0.02%
+13.3%
Q1 2014$211,000
-6.6%
7,125
-3.7%
0.02%
-11.8%
Q4 2013$226,0000.0%7,400
+3.5%
0.02%
-15.0%
Q3 2013$226,0007,1500.02%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,839,263$27,791,0009.88%
Broadfin Capital, LLC 1,696,754$25,638,0005.02%
HARVEY CAPITAL MANAGEMENT INC 1,057,800$15,982,0004.96%
ArrowMark Colorado Holdings LLC 578,750$8,745,0002.35%
FCG ADVISORS, LLC 140,805$2,128,0001.73%
EMERALD MUTUAL FUND ADVISERS TRUST 600,471$9,073,0001.54%
OAK RIDGE INVESTMENTS LLC 2,782,714$42,047,0001.32%
Lisanti Capital Growth, LLC 139,340$2,510,0001.20%
EMERALD ADVISERS, LLC 1,193,198$18,029,0001.10%
SECTORAL ASSET MANAGEMENT INC 2,302,428$34,790,0001.03%
View complete list of NPS PHARMACEUTICALS INC shareholders